142 related articles for article (PubMed ID: 38351735)
21. Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation.
Finazzi MC; Weber A; Pavoni C; Grassi A; Micò MC; Algarotti A; Lussana F; Rambaldi A
Bone Marrow Transplant; 2024 Jun; 59(6):751-758. PubMed ID: 38402345
[TBL] [Abstract][Full Text] [Related]
22. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
[TBL] [Abstract][Full Text] [Related]
23. Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Zhu KE; Xu Y; Wu D; Zhong J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):61-5. PubMed ID: 12513840
[TBL] [Abstract][Full Text] [Related]
24. Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab.
Wu C; Manchen P; Edelman A; Husnain M; Katsanis E; Fuchs D; Stephens L; Khurana S
J Hematol; 2023 Dec; 12(6):277-282. PubMed ID: 38188476
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of a pure red cell aplasia patient following ABO-mismatched hematopoietic stem cell transplantation from a sibling donor with multiple sclerosis.
Tavakoli F; Mohammadian M; Ghorbi MD; Shahsavan S; Halvachi D; Parkhideh S; Roshandel E
Transpl Immunol; 2023 Aug; 79():101863. PubMed ID: 37236515
[TBL] [Abstract][Full Text] [Related]
26. Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.
Aung FM; Lichtiger B; Bassett R; Liu P; Alousi A; Bashier Q; Ciurea SO; de Lima MJ; Hosing C; Kebriaei P; Nieto Y; Oran B; Parmar S; Qazilbash M; Shah N; Khouri I; Champlin RE; Popat U
Br J Haematol; 2013 Mar; 160(6):798-805. PubMed ID: 23330820
[TBL] [Abstract][Full Text] [Related]
27. Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia.
Aung FM; Lichtiger B; Rondon G; Yin CC; Alousi A; Ahmed S; Andersson BS; Bashir Q; Ciurea SO; Hosing C; Jones R; Kebriaei P; Khouri I; Nieto Y; Oran B; Parmar S; Qazilbash M; Shah N; Shpall EJ; Champlin RE; Popat U
Biol Blood Marrow Transplant; 2016 May; 22(5):961-5. PubMed ID: 26921820
[TBL] [Abstract][Full Text] [Related]
28. Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.
Quek J; Lee JJ; Lim FL; Diong C; Goh YT; Gopalakrishnan S; Ho A; Hwang W; Koh M; Loh Y; Linn YC
Transfusion; 2019 Jan; 59(1):335-339. PubMed ID: 30467850
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors.
Hirokawa M; Fukuda T; Ohashi K; Hidaka M; Ichinohe T; Iwato K; Kanamori H; Murata M; Sakura T; Imamura M; Adachi S; Suzuki R; Morishima Y; Sakamaki H;
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1026-32. PubMed ID: 23583828
[TBL] [Abstract][Full Text] [Related]
30. Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.
Curley C; Pillai E; Mudie K; Western R; Hutchins C; Durrant S; Kennedy GA
Transfusion; 2012 Feb; 52(2):291-7. PubMed ID: 21848968
[TBL] [Abstract][Full Text] [Related]
31. Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease.
Dovern E; Biemond BJ; Nur E
Front Immunol; 2023; 14():1212007. PubMed ID: 37426651
[TBL] [Abstract][Full Text] [Related]
32. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
[TBL] [Abstract][Full Text] [Related]
33. Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
Tomac G; Bojanić I; Mazić S; Vidović I; Raos M; Ćepulić BG; Seiwerth RS; Kelečić J; Labar B
Blood Transfus; 2018 Jul; 16(4):397-404. PubMed ID: 28488966
[TBL] [Abstract][Full Text] [Related]
34. Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review.
Yang MH; Hsu HC
Ann Hematol; 2001 May; 80(5):299-301. PubMed ID: 11446734
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC.
Longval T; Leprêtre AC; Ravinet A; Fayard A; Forcade E; Coman T; Redjoul R; Berceanu A; Buchbinder N; Berlie G; Mappoura M; Giannotti F; Chevillon F; Robin M; Peffault de Latour R; Sicre de Fontbrune F;
Bone Marrow Transplant; 2024 Jun; 59(6):893-895. PubMed ID: 38461290
[No Abstract] [Full Text] [Related]
36. The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from Kostmann syndrome.
Ebihara Y; Manabe A; Tsuruta T; Ishikawa K; Hasegawa D; Ohtsuka Y; Kawasaki H; Ogami K; Wada Y; Kanda T; Tsuji K
Int J Hematol; 2007 Dec; 86(5):446-50. PubMed ID: 18192114
[TBL] [Abstract][Full Text] [Related]
37. Immuno-Hematologic Complexity of ABO-Incompatible Allogeneic HSC Transplantation.
Matteocci A; Pierelli L
Cells; 2024 May; 13(10):. PubMed ID: 38786038
[TBL] [Abstract][Full Text] [Related]
38. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
[TBL] [Abstract][Full Text] [Related]
39. Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report.
Wang J; Zhu H; Miao K
Ann Hematol; 2024 May; 103(5):1775-1777. PubMed ID: 38556531
[TBL] [Abstract][Full Text] [Related]
40. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.
Verholen F; Stalder M; Helg C; Chalandon Y
Eur J Haematol; 2004 Dec; 73(6):441-6. PubMed ID: 15522068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
